|
Net loss of Emmessar Biotech & Nutrition reported to Rs 0.07 crore in the quarter ended March 2025 as against net profit of Rs 0.27 crore during the previous quarter ended March 2024. Sales rose 25.00% to Rs 0.10 crore in the quarter ended March 2025 as against Rs 0.08 crore during the previous quarter ended March 2024. For the full year,net profit declined 50.77% to Rs 0.32 crore in the year ended March 2025 as against Rs 0.65 crore during the previous year ended March 2024. Sales rose 8.93% to Rs 0.61 crore in the year ended March 2025 as against Rs 0.56 crore during the previous year ended March 2024. | Particulars | Quarter Ended | Year Ended | | Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. | | Sales | 0.10 | 0.08 | 25 | 0.61 | 0.56 | 9 | | OPM % | -330.00 | -487.50 | - | -155.74 | -192.86 | - | | PBDT | 0.28 | 0.09 | 211 | 1.06 | 0.91 | 16 | | PBT | 0.26 | 0.07 | 271 | 0.96 | 0.81 | 19 | | NP | -0.07 | 0.27 | PL | 0.32 | 0.65 | -51 | Powered by Capital Market - Live News
|